The landscape of global health has been irrevocably altered, placing biosafety and infection control from a behind-the-scenes necessity to a frontline investment megatrend. This sector, encompassing everything from advanced personal protective equipment (PPE) and disinfectants to sophisticated air filtration systems and diagnostic testing, is no longer a reactive market. It has evolved into a proactive,